6618 — JD Health International Income Statement
0.000.00%
Last trade - 00:00
- HK$72.87bn
- HK$29.31bn
- CNY53.53bn
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | PROSPECTUS | ARS | ARS | ARS | PRESS |
Standards: | IFRS | IFRS | IFRS | IFRS | — |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 10,842 | 19,383 | 30,682 | 46,736 | 53,530 |
Cost of Revenue | |||||
Gross Profit | 2,812 | 4,917 | 7,197 | 9,892 | 11,865 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 10,410 | 18,983 | 31,903 | 46,701 | 52,636 |
Operating Profit | 432 | 399 | -1,221 | 35.6 | 894 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -835 | -17,072 | -901 | 696 | 2,693 |
Provision for Income Taxes | |||||
Net Income After Taxes | -972 | -17,235 | -1,073 | 383 | 2,143 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | -972 | -17,234 | -1,074 | 380 | 2,142 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -972 | -17,234 | -1,074 | 380 | 2,142 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.31 | -7.8 | -0.347 | 0.121 | 0.677 |
Dividends per Share |